Phage-Displayed scFv Library for Antibody Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing antibodies are time-consuming, costly, and inefficient, particularly for antigens with low solubility, low immunogenicity, or toxicity, as they require complex hybridoma techniques that cannot be applied universally.
Innovation Solution
A phage-displayed single-chain variable fragment (scFv) library is developed, comprising specific canonical structure combinations and aromatic residue distributions, allowing for the generation of antibodies with binding affinity and specificity to specific antigens through a more streamlined process involving nucleic acid sequencing and site-directed mutagenesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If hybridoma techniques are used to produce antibodies, then antibody production can be achieved, but the process becomes time-consuming and costly
Solution Approach 1:
The patent segments the antibody structure into variable regions (VH and VL) that can be independently manipulated and recombined. By separating the constant regions from the variable regions and using phage display technology to present only the variable fragments, the complex hybridoma process is simplified into a more direct molecular biology approach that reduces time and complexity while maintaining antibody production capability
Solution Approach 2:
The patent uses phage display technology to create copies of antibody variable regions on phage surfaces. Instead of generating antibodies through complex cell fusion and cloning, the system creates multiple copies of scFv libraries on phage particles, allowing for high-throughput screening and selection of antigen-binding fragments without the time-consuming hybridoma process
2Productivity
If hybridoma techniques are used to produce antibodies, then antibody production can be achieved, but the manufacturing cost increases
Solution Approach 1:
The patent employs phage particles as disposable vectors to display antibody fragments. The phage-displayed scFv libraries can be produced in large quantities at low cost using bacterial culture systems, eliminating the need for expensive animal immunization and hybridoma maintenance. The phage particles serve as temporary, disposable carriers that can be screened and selected without requiring complex biological systems
Solution Approach 2:
The patent replaces the complex biological system of hybridoma cell fusion and culture with a more controllable in vitro selection system using phage display. By substituting cellular machinery with biochemical and biophysical selection methods (such as affinity selection and ELISA-based screening), the manufacturing process becomes more scalable, reproducible, and cost-effective
3Adaptability or versatility
If hybridoma techniques are used, then antibodies can be produced, but the method cannot be applied to antigens with low solubility, low immunogenicity, or toxicity
Solution Approach 1:
The patent extracts only the essential antigen-binding variable regions (VH and VL) from complete antibodies and displays them as single-chain fragments on phage surfaces. By removing the constant regions and focusing solely on the scFv portion, the system can screen and select binding fragments directly without requiring full antibody production through immunization. This extraction approach enables the use of synthetic or recombinant antigens that would be unsuitable for traditional immunization methods
Solution Approach 2:
The patent creates a universal phage display platform that can accommodate diverse antigens including those with low solubility, low immunogenicity, or toxicity. The system uses a standardized scFv library and phage display methodology that can be applied to any antigen of interest, whether natural or synthetic, soluble or insoluble, without requiring modification of the core technology. This universal approach replaces the antigen-specific immunization process with a通用的 molecular biology platform
Data Source
AI summary
Disclosed herein is a phage-displayed single-chain variable fragment (scFv) library, that comprised a plurality of phage-displayed scFvs characterized with (1) a specific CS combination; (2) a specific distribution of aromatic residues in each CDR; and (3) a specific sequence in each CDR. The present scFv library could be used to efficiently produce different antibodies with binding affinity to different antigens. Accordingly, the present disclosure provides a potential means to generate different antigen-specific antibodies promptly in accordance with the need in experimental researches and/or clinical applications.